Neuropace INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
NPCE
Neuropace INCNeuroPace, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 5, 2026, to elect directors and ratify the appointment of its independent auditor.
NASDAQ
NPCE
Neuropace INCNeuropace, Inc. has filed a definitive proxy statement with the SEC, soliciting material pursuant to Section 240.14a-12.
NASDAQ
NPCE
Neuropace INCDEF: NeuroPace, Inc. Announces Annual Stockholders Meeting to Elect Directors and Ratify Accounting Firm
NeuroPace, Inc. will hold its Annual Meeting of Stockholders virtually on June 6, 2025, to elect directors and ratify the selection of PricewaterhouseCoopers LLP as its independent accounting firm.
NASDAQ
NPCE
Neuropace INCNeuropace, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
NPCE
Neuropace INCNeuroPace, Inc. will hold its Annual Meeting of Stockholders virtually on June 7, 2024, to elect Class III directors and ratify the selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm.